Clinical Trials in Bad Oeynhausen, Germany
17 recruiting
Showing 1–19 of 19 trials
Recruiting
Phase 3
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Kidney Disease, Chronic
Boehringer Ingelheim11,000 enrolled399 locationsNCT06531824
Recruiting
Phase 3
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Cardiovascular DiseasesHypertensionDiabetes Mellitus, Type 2
Boehringer Ingelheim11,800 enrolled1153 locationsNCT07064473
Recruiting
Phase 3
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Novo Nordisk A/S1,280 enrolled285 locationsNCT07207811
Recruiting
Not Applicable
The Fourth Left Atrial Appendage Occlusion Study
Atrial FibrillationStroke, IschemicSystemic Embolism
Hamilton Health Sciences Corporation4,000 enrolled127 locationsNCT05963698
Recruiting
Not Applicable
BaLloon-based PFA Ablation poST Approval Outcomes for PAF and PersAF
Atrial FibrillationAtrial ArrhythmiaPersistent Atrial Fibrillation+1 more
Abbott Medical Devices300 enrolled22 locationsNCT07181590
Recruiting
Phase 1Phase 2
Safety and Efficacy of Induced Pluripotent Stem Cell-derived Engineered Human Myocardium as Biological Ventricular Assist Tissue in Terminal Heart Failure
Heart Failure
University Medical Center Goettingen53 enrolled3 locationsNCT04396899
Recruiting
Phase 3
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Heart Failure
AstraZeneca11,300 enrolled917 locationsNCT06677060
Recruiting
REdo Transcatheter Aortic VALVE Implantation for the Management of Transcatheter Aortic Valve Failure
Aortic Valve Stenosis
The Leeds Teaching Hospitals NHS Trust550 enrolled53 locationsNCT06557798
Recruiting
Phase 3
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
Atrial FibrillationStrokeBleeding
Icahn School of Medicine at Mount Sinai3,200 enrolled101 locationsNCT04045665
Recruiting
Phase 3
A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes
Diabetes Mellitus, Type 1
Novo Nordisk A/S877 enrolled184 locationsNCT07076199
Recruiting
Not Applicable
Corheart 6 LVAS Study
Refractory Heart Failure
Shenzhen Core Medical Technology CO.,LTD.53 enrolled11 locationsNCT05876000
Recruiting
Not Applicable
Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO-EU Trial
Mitral Regurgitation
Medtronic Cardiovascular400 enrolled37 locationsNCT05496998
Recruiting
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Heart FailureArrhythmiaBradycardia+1 more
Medtronic20,000 enrolled318 locationsNCT00271180
Recruiting
CytOSorb TreatMent Of Critically Ill PatientS Registry
SepsisLiver Transplant; ComplicationsPancreatitis+15 more
CytoSorbents, Inc3,000 enrolled28 locationsNCT05146336
Recruiting
The ReTAVI Prospective Observational Registry
Structural Valve DeteriorationStructural Valve DegenerationSymptomatic Patients Who Have Had Transcatheter Heart Valve (THV) Failure+2 more
Institut für Pharmakologie und Präventive Medizin250 enrolled62 locationsNCT05601453
Recruiting
Not Applicable
Preventive Catheter Ablation for Ventricular arrhythmiaS in Patients With End-sTage Heart faiLure
Heart FailureCardiomyopathy IschemicCatheter Ablation+3 more
Heart and Diabetes Center North-Rhine Westfalia160 enrolled1 locationNCT06556485
Recruiting
Real World European Investigation of Safety and Clinical Efficacy of the EVOQUE System (TRISCEND III EU)
Cardiovascular DiseasesTricuspid Valve RegurgitationHeart Valve Diseases
Edwards Lifesciences500 enrolled2 locationsNCT06569602
Recruiting
Not Applicable
Pulmonary Artery Sensor System Pressure Monitoring to Improve Heart Failure (HF) Outcomes
Heart Failure
IHF GmbH - Institut für Herzinfarktforschung554 enrolled33 locationsNCT04398654
Recruiting
REDUCE LAP-HF III Corvia Protocol 1701
Heart Failure
Corvia Medical500 enrolled27 locationsNCT03191656